RIVOLTA, ILARIA
 Distribuzione geografica
Continente #
NA - Nord America 14.818
EU - Europa 7.302
AS - Asia 6.760
SA - Sud America 1.041
Continente sconosciuto - Info sul continente non disponibili 947
AF - Africa 174
OC - Oceania 14
Totale 31.056
Nazione #
US - Stati Uniti d'America 14.044
SG - Singapore 2.350
IT - Italia 2.211
CN - Cina 1.515
DE - Germania 1.195
VN - Vietnam 918
HK - Hong Kong 885
RU - Federazione Russa 830
BR - Brasile 803
CA - Canada 656
SE - Svezia 623
IE - Irlanda 532
GB - Regno Unito 395
UA - Ucraina 360
FR - Francia 253
IN - India 237
FI - Finlandia 229
AT - Austria 157
BD - Bangladesh 153
DK - Danimarca 103
ID - Indonesia 97
TR - Turchia 85
ES - Italia 81
KR - Corea 78
IQ - Iraq 76
AR - Argentina 75
NL - Olanda 71
PL - Polonia 66
MX - Messico 64
ZA - Sudafrica 64
PK - Pakistan 58
JP - Giappone 52
BE - Belgio 51
EC - Ecuador 43
SA - Arabia Saudita 41
PH - Filippine 33
CH - Svizzera 31
CO - Colombia 31
VE - Venezuela 26
CL - Cile 23
UZ - Uzbekistan 22
MA - Marocco 19
PY - Paraguay 19
RO - Romania 19
AE - Emirati Arabi Uniti 18
HU - Ungheria 17
IR - Iran 17
JO - Giordania 16
KE - Kenya 16
MY - Malesia 16
BG - Bulgaria 15
EG - Egitto 14
EU - Europa 14
LT - Lituania 13
AZ - Azerbaigian 11
NP - Nepal 11
AU - Australia 10
DZ - Algeria 10
ET - Etiopia 10
TN - Tunisia 10
AL - Albania 9
CR - Costa Rica 8
PT - Portogallo 8
UY - Uruguay 8
IL - Israele 7
PS - Palestinian Territory 7
TH - Thailandia 7
TT - Trinidad e Tobago 7
BO - Bolivia 6
BY - Bielorussia 6
CZ - Repubblica Ceca 6
GE - Georgia 6
HN - Honduras 6
KZ - Kazakistan 6
RS - Serbia 6
SN - Senegal 6
CX - Isole del Natale 5
JM - Giamaica 5
LB - Libano 5
NG - Nigeria 5
NI - Nicaragua 5
OM - Oman 5
PE - Perù 5
SC - Seychelles 5
DO - Repubblica Dominicana 4
KG - Kirghizistan 4
PA - Panama 4
SK - Slovacchia (Repubblica Slovacca) 4
SV - El Salvador 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AO - Angola 3
BH - Bahrain 3
BS - Bahamas 3
BT - Bhutan 3
GR - Grecia 3
GT - Guatemala 3
NZ - Nuova Zelanda 3
BB - Barbados 2
BJ - Benin 2
EE - Estonia 2
Totale 30.091
Città #
Ann Arbor 2.122
Singapore 1.443
Ashburn 1.263
San Jose 887
Woodbridge 886
Hong Kong 873
Frankfurt am Main 817
Chandler 734
Fairfield 722
Milan 621
Wilmington 529
Dublin 519
Houston 502
Toronto 446
Dallas 384
Santa Clara 353
New York 345
Jacksonville 341
Dearborn 312
Seattle 273
Ho Chi Minh City 272
Council Bluffs 254
Los Angeles 230
Rome 228
Beijing 219
Cambridge 214
Princeton 199
Chicago 195
The Dalles 171
Hanoi 169
Munich 153
Nanjing 142
Vienna 142
Helsinki 124
Shanghai 116
Hefei 111
Lauterbourg 102
Columbus 92
Buffalo 91
Moscow 87
São Paulo 82
Lawrence 80
Altamura 73
Guangzhou 69
Seoul 69
Jakarta 65
Boardman 59
Lachine 54
London 50
Phoenix 50
San Diego 49
Orem 48
Dong Ket 46
Montreal 45
Nanchang 44
Washington 43
Brooklyn 42
Brussels 42
Denver 40
Fremont 40
Ottawa 39
Haiphong 37
Atlanta 36
Andover 35
Chennai 33
Tokyo 33
Da Nang 32
Warsaw 32
Bologna 31
Johannesburg 31
Philadelphia 31
Turin 31
Changsha 30
Rio de Janeiro 30
Baghdad 29
Shenyang 29
Bari 28
Bergamo 28
Tianjin 28
Kraków 27
Pune 27
Turku 27
Zhengzhou 26
Falls Church 25
Lahore 25
Nuremberg 24
Figino 23
Jinan 23
Manchester 21
Poplar 21
Verona 21
Naples 20
Norwalk 20
Stockholm 20
Tashkent 20
Edmonton 19
Hebei 19
Mumbai 19
Brasília 17
Brugherio 17
Totale 19.837
Nome #
Vander Fisiologia 784
Innovative and Efficient Oral Delivery Method of APOA-1Milano Muteins Which Retain Anti-Atherosclerotic and Anti-Inflammatory Properties 561
APOA-1Milano muteins, orally delivered via genetically modified rice, show anti-atherogenic and anti-inflammatory properties in vitro and in Apoe −/− atherosclerotic mice 511
Cardiac and neuronal HCN channelopathies 502
Two novel SCN5A loss-of-function mutations affect patients with severe arrhytmogenic syndromes 469
Effect of the ketogenic diet in excitable tissues 452
Simultaneous overexpression of human E5NT and ENTPD1 protects porcine endothelial cells against H2O2-induced oxidative stress and cytotoxicity in vitro 450
Modulation of the intrinsic neuronal excitability by multifunctional liposomes tailored for treatment of Alzheimer’s disease 449
Evaluation of gold nanoparticles biocompatibility: a multiparametric study on cultured endothelial cells and macrophages 423
Simultaneous overexpression of functional human HO-1, E5NT and ENTPD1 protects murine fibroblasts against TNF-α-induced injury in vitro 422
HCN ion channels and accessory proteins in epilepsy: genetic analysis of a large cohort of patients and review of the literature 420
A novel KCNJ2 mutation identified in an autistic proband affects the single channel properties of Kir2.1 409
Hypoxia-induced modifications in plasma membranes and lipid microdomains in A549 cells and primary human alveolar cells 407
Binary biocompatible CNCs-Gelatine hydrogel as 3D scaffolds suitable for cell culture adhesion and growth 401
Progressive epileptic encephalopathy associated with a novel HCN2 mutation 387
Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy 385
Respiratory Mechanics and Fluid Dynamics After Lung Resection Surgery 384
Brugada syndrome genetics is associated with phenotype severity 380
Tissue specificity of mitochondrial adaptations in rats after 4 weeks of normobaric hypoxia 372
Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer's disease 356
Hepcidin regulation in a mouse model of acute hypoxia 351
Role of the Air-Blood Barrier Phenotype in Lung Oxygen Uptake and Control of Extravascular Water 350
A novel de novo HCN2 loss-of-function variant causing developmental and epileptic encephalopathy treated with a ketogenic diet 348
Iron oxide nanoparticles surface coating and cell uptake affect biocompatibility and inflammatory responses of endothelial cells and macrophages 346
Do the functional properties of HCN1 mutants correlate with the clinical features in epileptic patients? 341
SCN4A mutation as modifying factor of Myotonic Dystrophy Type 2 phenotype 340
Interstitial pressure and lung oedema in chronic hypoxia 336
Cardiopulmonary Consequences of Post Thoracic Surgery Pulmonary Hypertension: Cause or Consequence of Lung Edema? 332
From morphological heterogeneity at alveolar level to the overall mechanical lung behavior: an in vivo microscopic imaging study 321
How ketogenic diet may be beneficial in controlling neuronal excitability? 320
Effect of nanoparticles binding ß-amyloid peptide on nitric oxide production by cultured endothelial cells and macrophages 312
SCN4A as modifier gene in patients with myotonic dystrophy type 2 311
Changes in the mechanical properties of the respiratory system during the development of interstitial lung edema 310
Innovative therapies and nanomedicine applications for the treatment of alzheimer’s disease: A state-of-the-art (2017–2020) 307
Novel SCN5A p.Val1667Asp Missense Variant Segregation and Characterization in a Family with Severe Brugada Syndrome and Multiple Sudden Deaths 301
Oxygen-loaded nanodroplets effectively abrogate hypoxia dysregulating effects on secretion of MMP-9 and TIMP-1 by human monocytes 299
Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells 297
Study of the effects of nanoliposomes engineered for the treatment of Alzheimer's disease on the electrical activity of cortical neurons 296
mRNA expression profile of selected oxygen sensing genes in the lung during recovery from chronic hypoxia 295
Dietary nanoparticles interact with gluten peptides and alter the intestinal homeostasis increasing the risk of celiac disease 294
The effect of nanoparticle uptake on cellular behavior: disrupting or enabling functions? 293
A biophysical model of intracellular distribution and perinuclear accumulation of particulate matter 291
Gold Branched Nanoparticles for Cellular Treatments 290
JMV5656, a novel derivative of TLQP-21, triggers the activation of a calcium-dependent potassium outward current in microglial cells 289
GSTM3 variant is a novel genetic modifier in Brugada syndrome, a disease with risk of sudden cardiac death 289
Accumulative Difference Image Protocol for Particle Tracking in Fluorescence Microscopy Tested in Mouse Lymphonodes 285
T-Type Calcium Channels: A Mixed Blessing 280
HCN1 novel mutations in familiar generalized epilepsy 276
Automated Patch-Clamp and Induced Pluripotent Stem Cell-Derived Cardiomyocytes: A Synergistic Approach in the Study of Brugada Syndrome 275
The expression of the rare caveolin-3 variant T78M alters cardiac ion channels function and membrane excitability 273
Experimental model to evaluate the effect of hydrothorax and lobar resection on lung compliance 273
Cardiac voltage-gated sodium channel Nav1.5 is regulated by Nedd4-2 mediated ubiquitination 270
Dynamic Investigation of Interaction of Biocompatible Iron Oxide Nanoparticles with Epithelial Cells for Biomedical Applications 269
Identification and functional characterisation of a new KCNJ2 mutation 269
Acetylation mediates Cx43 reduction caused by electrical stimulation 268
A novel KCNC1 gain-of-function variant causing developmental and epileptic encephalopathy: “Precision medicine” approach with fluoxetine 267
An outlook on the potential of Si nanocrystals as luminescent probes for bioimaging 265
Alveolar mechanics studied by in vivo microscopy imaging through intact pleural space 262
Lipid-based nanoparticles (NPs) with high binding affinity for amyloid-beta1-42 peptide modulate the barrier properties of a monolayer of endothelial cells 258
2H,3H-decafluoropentane-based nanodroplets: New perspectives for oxygen delivery to hypoxic cutaneous tissues 258
A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene 257
Rational design of a mutation to investigate the role of the brain protein TRIP8b in limiting the cAMP response of HCN channels in neurons 255
HCN1 mutation spectrum: From neonatal epileptic encephalopathy to benign generalized epilepsy and beyond 254
Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of cardiomyocytes 251
Remodelling of Membrane Rafts Expression in Lung Cells as an Early Sign of Mechanotransduction-Signalling in Pulmonary Edema 251
Functional Characterization of Two Variants at the Intron 6-Exon 7 Boundary of the KCNQ2 Potassium Channel Gene Causing Distinct Epileptic Phenotypes 250
‘In Vitro’, ‘In Vivo’ and ‘In Silico’ Investigation of the Anticancer Effectiveness of Oxygen-Loaded Chitosan-Shelled Nanodroplets as Potential Drug Vector 244
Unravelling Novel SCN5A Mutations Linked to Brugada Syndrome: Functional, Structural, and Genetic Insights 243
Computer simulation of wild-type and mutant human cardiac Na+ current 242
Genetics of Long QT, Brugada, and Other Channelopathies 239
Giovanni Alfonso Borelli, Giorgio Baglivi, and the origin of the heartbeat in the seventeenth century 238
Alterations of the Sialylation Machinery in Brugada Syndrome 237
BS-499656-002 Lethal Autoimmune Channelopathies: Nav1.5 Autoantibodies And Their Role In Sudden Cardiac Death 234
Dextran-shelled oxygen-loaded nanodroplets reestablish a normoxia-like pro-angiogenic phenotype and behavior in hypoxic human dermal microvascular endothelium 234
Invitro- Invivo fluctuation spectroscopies 233
The effect of exogenous surfactant on alveolar interdependence 233
Chitosan-shelled oxygen-loaded nanodroplets abrogate hypoxia dysregulation of human keratinocyte gelatinases and inhibitors: New insights for chronic wound healing 230
Cellular uptake of coumarin-6 as a model drug loaded in solid lipid nanoparticles 224
NaV1.5 autoantibodies in Brugada syndrome: pathogenetic implications 223
Ion Channel as Target for Drugs 220
Regional Differences in the protein patterns related to lung remodeling and oxygen sensing 217
Cardiac histological substrate in patients with clinical phenotype of Brugada syndrome 216
A novel de novo HCN1 loss-of-function mutation in genetic generalized epilepsy causing increased neuronal excitability 214
Silica encapsulation of luminescent silicon nanoparticles: Stable and biocompatible nanohybrids 209
Mechanistic considerations on the development of lung edema: Vascular, perivascular and molecular aspects from early stage to tissue and vascular remodeling stage 200
Nanoparticles modulate the stability of the nuclear structure interfering in the mechanical connection between plasma membrane and nucleus 199
Cellular interaction with Si- and Iron-based nanoparticles for bio-imaging. A study of biocompatibility (Conference Paper ) 197
Fisiologia Medica - Terza Edizione 196
Ion channels in the heart 194
Novel arrhythmogenic mechanism revealed by a long-QT syndrome mutation in the cardiac Na(+) channel 188
Bio-medical and sensor application of silicon nanoparticles 187
SCN4A as modifier gene in myotonic dystrophy type 2 (DM2) patients with early and severe myotonia 187
Cardiac sodium channel diseases 186
Comparative expression of two oxygen-dependent transcription factors (O2TF) in lungs, heart and skeletal muscles in a rat model of chronic hypoxia (CH) 183
Vander Fisiologia 180
Markovian model for wild-type and mutant (Y1795C and Y1795H) human cardiac Na/sup +/ channel 174
In silico assessment of Y1795C and Y1795H SCN5A mutations: implication for inherited arrhythmogenic syndromes 173
Modulation of cardiac sodium channel gating by protein kinase A can be altered by disease-linked mutation 169
A rabbit model of uremia-induced cardiomyopathy 168
Advances in the preparation of novel functionalized nanoparticles for bioimaging 165
Totale 29.425
Categoria #
all - tutte 96.456
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.456


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.266 0 0 164 153 72 120 95 78 63 112 123 286
2022/20232.945 321 865 342 302 208 431 24 133 191 25 55 48
2023/20241.833 56 64 84 127 232 473 337 52 137 48 27 196
2024/20254.214 225 424 168 284 385 245 228 202 444 611 315 683
2025/202610.604 1.097 502 928 1.223 1.288 556 1.500 462 910 746 667 725
2026/20271.214 321 517 376 0 0 0 0 0 0 0 0 0
Totale 31.056